Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone

This publication has 24 references indexed in Scilit:

• Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro¹
  Endocrinology, 1998
• Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1997
• Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
  Cell, 1997
• Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
  Endocrinology, 1996
• Modulation of osteoclast differentiation by local factors
  Bone, 1995
• Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
  Proceedings of the National Academy of Sciences, 1993
• Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro
  Journal of Bone and Mineral Research, 1991
• Cellular and Molecular Mechanisms in the Regulation and Function of Osteoclasts
  Published by Elsevier ,1991
• The Bone Marrow-Derived Stromal Cell Lines MC3T3-G2/PA6 and ST2 Support Osteoclast-Like Cell Differentiation in Cocultures with Mouse Spleen Cells
  Endocrinology, 1989
• OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
  Endocrinology, 1988